Literature DB >> 9385115

Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury.

P Cuevas1, D Reimers, F Carceller, V Martinez-Coso, M Redondo-Horcajo, I Saenz de Tejada, G Giménez-Gallego.   

Abstract

BACKGROUND: Apoptosis is a constant feature of reperfusion injury in ischemic cardiac myocytes, leading to late cell death. Since fibroblast growth factors (FGFs) inhibit apoptosis in differentiated cells, we hypothesized that FGF-1 (acidic FGF), in its native form, and a non-mitogenic isoform would attenuate myocardial ischemia-reperfusion- induced apoptosis. METHODS AND
RESULTS: The effect of native and non-mitogenic fibroblast growth factor-1 mutein (FGF-1 and m-FGF-1) on apoptosis assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method was tested in a rat model of 20 min regional myocardial ischemia and 24h reperfusion. Myocardial ischemia followed by reperfusion resulted in a high myocardial apoptosis rate in the area at risk. When given as a systemic bolus inmediately after myocardial ischemia, both FGF-1 and m-FGF-1 significantly reduced apoptosis (by 60 and 61.2, respectively; p<0.0001).
CONCLUSIONS: The programed myocyte cell death triggered by ischemia-reperfusion injury is attenuated by FGF-1 in its native or non mitogenic isoforms, suggesting that this effect does not depend on the mitogenic properties of this protein. FGF-1 would contribute to the functional preservation of the myocardium after acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385115

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  18 in total

1.  Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury.

Authors:  Hehe Cui; Na Li; Xiangdong Li; Kang Qi; Qing Li; Chen Jin; Tianjie Wang; Lian Duan; Leipei Jiang; Guihao Chen; Zhigang Wang; Cong Wei; Yuejin Yang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 2.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

3.  Green Tea Induced Cellular Proliferation and the Expression of Transforming Growth Factor-β1 in the Jejunal Mucosa of Fasting Rats.

Authors:  Thazhumpal C Mathew; Suad M Abdeen; Hussain Dashti; Sami Asfar
Journal:  Med Princ Pract       Date:  2017-03-07       Impact factor: 1.927

4.  Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Authors:  Seyed Javad Hoseini; Hamed Ghazavi; Fatemeh Forouzanfar; Baratali Mashkani; Ahmad Ghorbani; Elahe Mahdipour; Faezeh Ghasemi; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  DNA Cell Biol       Date:  2017-03-10       Impact factor: 3.311

Review 5.  Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair.

Authors:  Mei Xin; Eric N Olson; Rhonda Bassel-Duby
Journal:  Nat Rev Mol Cell Biol       Date:  2013-07-10       Impact factor: 94.444

6.  FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.

Authors:  Felix B Engel; Patrick C H Hsieh; Richard T Lee; Mark T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-10       Impact factor: 11.205

Review 7.  The role of miRNA regulation in fetal cardiomyocytes, cardiac maturation and the risk of heart disease in adults.

Authors:  Mitchell C Lock; Ross L Tellam; Kimberley J Botting; Kimberley C W Wang; Joseph B Selvanayagam; Doug A Brooks; Mike Seed; Janna L Morrison
Journal:  J Physiol       Date:  2018-06-28       Impact factor: 5.182

8.  Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity.

Authors:  Xiao-Bing Fu; Xiao-Kun Li; Tong Wang; Biao Cheng; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 9.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

Review 10.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.